Abstract. Fucoidan, the general term for sulfated polysaccharides, is reported to engage in various biological activities having anti-tumor, anti-coagulation and anti-viral effects. Though it has been investigated, the mechanism of its antitumor effects remains elusive. The current study examined the anti-tumor effects of fucoidan extracted from Okinawa mozuku on 15 human cancer cell lines (6 hepatocellular carcinomas, 1 cholangiocarcinoma, 1 gallbladder cancer, 2 ovarian cancers, 1 hepatoblastoma, 1 neuroblastoma and 3 renal cancers) using an MTT assay. Changes in apoptosis and the cell cycle were analyzed by flow cytometry. The results revealed that cell proliferation was suppressed in 13 cell lines in a time-and/or dose-dependent manner; this suppression was marked in the hepatocellular carcinoma, cholangiocarcinoma and gallbladder carcinoma cell lines. In contrast, proliferation of the neuroblastoma and 1 of the 2 ovarian carcinoma cell lines was not affected. The ratio of apoptotic cells significantly increased in 5 of the 6 hepatocellular carcinoma cell lines, and the ratio of G 2 /M cells increased in the 3 hepatocellular cell lines examined. These observations indicate that fucoidan is a potential anti-tumor agent for the treatment of bile duct cancers, such as hepatocellular carcinoma, cholangiocarcinoma and gall-bladder carcinoma.
Introduction
Malignant tumors are a major cause of death in humans and, though treatment methods for cancer have markedly progressed, curative regimens and protocols are still under investigation. At present, chemotherapy is regarded as the most effective treatment for solid tumors.
Recent studies have shown that the natural substances extracted from green tea (1) and marine products, among others, have favorable preventive effects against cancers. 'Mozuku' (brown seaweed) is a marine plant which grows offshore around Okinawa Island. It has attracted the attention of scientists as well as the general public, and is considered a food which has various beneficial effects on the body. Fucoidan, the major component of 'mozuku', is the general term used for sulfated polysaccharides, which are also found in other seaweeds such as 'wakame', 'hijiki', 'mekabu'. Sulfated polysaccharides are reported to engage in various biological activities having anti-tumor effects (2-6), antithrombin activity (7, 8) , anti-coagulant activity (9) and antiviral effects (10, 11) . Their anti-tumor effects have been investigated using various methods, but the mechanism of their action has remained elusive.
In order to increase the understanding of these anti-tumor effects, this in vitro study was conducted using 15 cell lines from 5 types of human cancers (liver cancer, cholangiocarcinoma, ovarian cancer, hepatoblastoma and neuroblastoma) along with fucoidan extracted from 'Okinawa mozuku'.
Materials and methods
Preparation of culture medium with fucoidan. Fucoidan solution was kindly provided by FCC Horiuchi & Co. (Kurume, Japan). The fucoidan was extracted from mozuku (Cladosiphon Okamuranus Tokida) collected from the shores of Okinawa Island in Japan, sold as a sea product (containing fucose 22.1 mg/100 mg) with government approval, and used as raw material for a health drink. The structure of the polysaccharide from C. okamuranus has been investigated previously (12, 13) .
The basal medium for cell culture was Dulbecco's modified Eagle's medium (Nissui Seiyaku Co., Tokyo, Japan) supplemented with 5% fetal bovine serum (Whittaker Bioproducts Inc., Walkersville, MD), 100 units/ml penicillin, and 100 μg/ml streptomycin (Gibco, Chagrin Falls, OH KMC-1, 50.64 μg for HAK-1B, 52.32 μg for KYN-2 and 76.25 μg for KMG-C. According to tumor type, the IC 50 was lowest in HCC and cholangiocarcinoma (Fig. 3) .
Results

Effect of fucoidan on morphological changes. Cell morphology
Effect of fucoidan on apoptosis.
Apoptosis was examined at 72 h of culture in the 6 cell lines that presented pronounced growth suppression in the MTT assay. The number of apoptotic cells increased significantly in the 5 HCC cell lines with the exception of KYN-1, indicating that fucoidan induced apoptosis (Fig. 4) .
Effect of fucoidan on the cell cycle. Flow cytometry of the 3 HCC cell lines (HAK-1A, KYN-2, KYN-3) revealed an increased number of cells in the G 2 /M phase at 72 h after the addition of the fucoidan solution (22.5 μg/ml) to the culture (Table I ).
Discussion
The current study examined the anti-tumor effect of Okinawa mozuku fucoidan on 15 human cancer cell lines. Chronological and/or dose-dependent suppression of cell proliferation was observed in 13 of the 15 lines (87%). Previous studies have reported direct anti-tumor effects of fucoidan on HTLV-1-infected T cell lines and primary ATL cells (24) , lymphoma cells (25) and a bronchopulmonary carcinoma cell line (NSCLC-N6) (4). The various possible mechanisms of fucoidan have also been explored, such as its anti-tumor effect induced by anti-angiogenesis (5), growth suppression due to immunopotentiation (26) , and the suppression of metastasis (27, 28) , but only on one cell line. This current study investigated the effects had by fucoidan from the same source at the same time on multiple cell lines.
The major components of fucoidan are L-fucose and sulfate content. Previous studies used fucoidan extracted from Fucus vesiculosus (25) , Ascophyllum nodosum (4,7), Sargassum kjellmanianum (29) , Sargassum thunbergii (26) or Cladosiphon okamuranus Tokida (24) , in which the percentage of L-fucose ranged from 12.6 to 36.0%, and the percentage of sulfate content from 8 to 25%. Sulfate content was also reported to be a factor with growth suppression effects (4, 29) . The fucoidan solution used in the current study contained these 2 substances within the above-mentioned ranges.
In this study, the suppression of cell proliferation was more apparent in the cell lines of HCC, cholangiocarcinoma and gallbladder carcinoma than in those of neuroblastoma, hepatoblastoma, ovarian carcinoma and renal carcinoma. The growth suppression effects also varied among the cell lines of the same tumor type. The IC 50 values of the HAK-1B (HCC) and KMC-1 (cholangiocarcinoma) cell lines were additionally markedly lower in comparison to previously reported data (4, 25) . These findings indicate that the anti-tumor effects of fucoidan vary according to tumor type and, along with previous findings, demonstrate the anti-tumor effects of fucoidan on colon cancer but not on mammary tumors (30) . This indicates that the supression of cell proliferation does not occur in all cancer cell lines. The mechanism behind the more potent growth suppression observed in the HCC and cholangiocarcinoma cell lines should therefore be explored in future studies. Haneji et al (24) reported that apoptosis is induced by the activation of the caspase pathway, and Aisa et al (25) demonstrated anti-tumor effects accompanied by the activation of the caspase pathway and the down-regulation of the ERK pathway. In the current study, 5 of the 6 HCC cell lines presented a significant dose-dependent increase in apoptosis. The activation of caspase-3 and -9 in HAK-1B, which presented marked apoptosis, was therefore investigated. However, no clear activation was observed (data not shown), indicating that the anti-tumor effects of fucoidan on HCC cell lines could be associated with a different pathway.
With regard to cell cycle effect, Haneji et al (24) reported that fucoidan induced the accumulation of cells in the G 1 /S phase, and Riou et al (4) observed that anti-tumor effects were accompanied by a G 1 phase block. On the other hand, Aisa et al (25) reported no effect on the cell cycle. The current findings regarding the cell cycle demonstrate for the first time an increase in cells in the G 2 /M phase.
In the current study, fucoidan suppressed cell proliferation in a time-and dose-dependent manner at various degrees, and its effects were particularly pronounced in the HCC, cholangiocarcinoma and gallbladder carcinoma cell lines. The results indicate that the mechanisms of fucoidan action include the induction of apoptosis and the inhibition of the cell cycle.
At present, the clinical results of treatment for advanced HCC and cholangiocarcinoma are unsatisfactory. Fucoidan could be a potential anti-tumor remedy for specific cancers, such as HCC or cholangiocarcinoma. More detailed information on the anti-tumor effects of fucoidan should therefore be obtained in future animal studies. Table I . Flow cytometric analysis of the effect of fucoidan (22.5 μg/ml) on the cell cycle of hepatocellular carcinoma cell lines at 24, 48 and 72 h of culture.
-----------------------------------------------------------------------------------------------------24 h 48 h 72 h ------------------------------------------------------------Cell line
Cell cycle Control Fucoidan Control Fucoidan Control Fucoidan  ---------------------------------------------------------------------------------------------------- 
-----------------------------------------------------------------------------------------------------
Control, cells cultured without fucoidan. Fucoidan, cells cultured with fucoidan (22.5 μg/ml). Values represent the percentage of cells at each phase of the cell cycle.
